Soleno Therapeutics Inc (SLNO NASDAQ) stock market data APIs
$82.1217
-0.93(-1.1%)
as of July 11, 2025
Try our APIs with
free plan!
Soleno Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Prev. Close
82.1217
Open
81.193
High
83.9516
Low
80.5573
52 wk Range
41.5-90.3199
Market Cap
4 302 M
Shares Outstanding
52 747 K
EPS
-0.95
Beta
-2.672
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Soleno Therapeutics Inc data using free add-ons & libraries
Get Soleno Therapeutics Inc Fundamental Data
Soleno Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -202 130 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-06
- EPS/Forecast: -0.9275
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Soleno Therapeutics Inc News
New
Stifel reiterates Buy rating on Soleno Therapeutics stock amid strong Vykat launch
Investing.com - Stifel has reiterated its Buy rating and $115.00 price target on Soleno Therapeutics Inc. (NASDAQ:SLNO) following the company’s preliminary second-quarter results and capital raise. ...
Soleno sales of new Prader-Willi drug rise faster than expected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The first marketed treatment for the insatiable hunge...
Sector Update: Health Care Stocks Mixed Premarket Thursday
Health care stocks were mixed premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) wa PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Soleno Therapeutics prices $200M public offering
* Soleno Therapeutics (NASDAQ:SLNO [https://seekingalpha.com/symbol/SLNO]) priced a public offering of 2.35M shares at $85 each, aiming to raise ~$200M in gross proceeds. * Underwriters have a 30-...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
